Women's Health Stocks
Targeted healthcare delivery and consumer goods providers in this vertical address the physiological requirements and wellness preferences unique to female biology across life stages ranging from reproductive health to post-menopausal care.
As of Oct 23, 2026, Women's Health has 26 US-listed companies worth $91.7B combined. The median member moved +0.0% over the past week; MYGN led among the 25 largest at +46.2% and DARE trailed at -10.9%.
Companies in Women's Health
- NTRA – Natera Inc, $57.9B
- COO – The Cooper Companies, Inc, $11.7B
- BLLN – BillionToOne, Inc. Class A Common Stock, $4.8B
- OGN – Organon & Co, $3.6B
- SUPN – Supernus Pharmaceuticals Inc, $2.4B
- MD – Mednax Inc, $2.4B
- PBH – Prestige Brand Holdings Inc, $2.4B
- PGNY – Progyny Inc, $2.2B
- ESTA – Establishment Labs Holdings Inc, $1.8B
- REF – Reformation Inc., $807M
- MCTA – Charming Medical Limited Class A Ordinary Shares, $446M
- MYGN – Myriad Genetics Inc, $396M
- MOVE – Movano Inc, $276M
- UTMD – Utah Medical Products Inc, $237M
- SERA – Sera Prognostics Inc, $80.5M
- QTI – QT Imaging Holdings, Inc. Common Stock, $39.2M
- CNTX – Context Therapeutics Inc, $28.9M
- ATOS – Atossa Genetics Inc, $24.3M
- TXMD – TherapeuticsMD Inc, $23.8M
- DARE – Dare Bioscience Inc, $13.5M
- FEMY – Femasys Inc, $13.1M
- PLSM – Pulsenmore Ltd. Ordinary Shares, $11.8M
- IVF – INVO Fertility, Inc., $3.8M
- EVFM – Evofem Biosciences Inc, $980,722
- VIVE – Viveve Medical Inc, $2,144
- UTRS – Minerva Surgical Inc, $887